Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
FIRES
MCID: FBR064
MIFTS: 38

Febrile Infection-Related Epilepsy Syndrome (FIRES)

Categories: Neuronal diseases, Rare diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Febrile Infection-Related Epilepsy Syndrome

About this section

MalaCards integrated aliases for Febrile Infection-Related Epilepsy Syndrome:

Name: Febrile Infection-Related Epilepsy Syndrome 20 58
Acute Encephalitis with Refractory Repetitive Partial Seizures 20 58 36
Acute Non-Herpetic Encephalitis with Severe Refractory Status Epilepticus 20 58
Fever-Induced Refractory Epileptic Encephalopathy in School-Aged Children 20 58
Severe Refractory Status Epilepticus Owing to Presumed Encephalitis 20 58
Devastating Epileptic Encephalopathy in School-Aged Children 20 58
Idiopathic Catastrophic Epileptic Encephalopathy 20 58
Desc Syndrome 20 58
Aerrps 20 58
Fires 20 58
Status Epilepticus Owing to Presumed Encephalitis 20

Characteristics:

Orphanet epidemiological data:

58
febrile infection-related epilepsy syndrome
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Germany),1-9/100000 (Europe); Age of onset: All ages; Age of death: normal life expectancy;

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)
Orphanet: 58  
Rare neurological diseases


Sources

Summaries for Febrile Infection-Related Epilepsy Syndrome

About this section
GARD : 20 FIRES (Febrile Infection-Related Epilepsy Syndrome) is a sub-type of cryptogenic new-onset refractory status epilepticus (NORSE). NORSE describes a condition in which a healthy person who has not had seizures before, begins having seizures. Over a few days, the seizures increase in frequency and length and evolve into status epilepticus (SE). SE is a prolonged seizure or cluster of seizures during which a person does not regain consciousness between seizures. The seizure activity is considered refractory because it cannot be controlled with standard anti-seizure medications. Cryptogenic means all possible known causes have been ruled out. People with the sub-type FIRES have a fever a day to two weeks before the beginning of the seizures. The fever may or may not be present when SE begins, but no infection can be found to be causing SE. SE can last for days, weeks, or even months. Of note, FIRES previously was considered a separate condition that occurred only in children, while NORSE was described only in adults. However, there is now consensus that FIRES and NORSE without a prior fever can both be described in people of any age. You can learn more about FIRES on GARD's NORSE Information Page.

MalaCards based summary : Febrile Infection-Related Epilepsy Syndrome, also known as acute encephalitis with refractory repetitive partial seizures, is related to epilepsy and status epilepticus. An important gene associated with Febrile Infection-Related Epilepsy Syndrome is PCDH19 (Protocadherin 19). The drugs Glycerol and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include prostate, eye and spinal cord, and related phenotypes are eeg abnormality and developmental regression

KEGG : 36 Acute encephalitis with refractory, repetitive partial seizures (AERRPS) is a new epileptic syndrome mainly affecting children. AERRPS has not been perceived in Western countries, although it is widely recognized in Japan. They usually present abruptly with seizure or impaired consciousness as well as high-grade fever following antecedent infection. Seizures in AERRPS are almost exclusively of localized origin, whose semiology includes eye deviation, hemifacial twitching, hemiclonic convulsion, and autonomic manifestations. Partial seizures are brief, but repeat with increasing frequency and develop status epilepticus at nadir. It is followed by continuous transition to intractable epilepsy without a latent period. They are uniformly resistant to conventional antiepileptic drugs. In most cases, high-dose barbiturate treatment is necessary during the acute phase of the illness. Benzodiazepines, mainly midazolam, were partially effective in some patients. The pathogenesis of AERRPS is still poorly understood. It is currently suspected to represent an inflammatory disorder of the central nervous system.

Wikipedia : 74 Febrile infection-related epilepsy syndrome (FIRES) is an epilepsy syndrome in which new-onset... more...

Sources

Related Diseases for Febrile Infection-Related Epilepsy Syndrome

About this section

Diseases related to Febrile Infection-Related Epilepsy Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 67)
# Related Disease Score Top Affiliating Genes
1 epilepsy 31.0 SCN1A POLG PCDH19
2 status epilepticus 30.8 SCN1A POLG PCDH19
3 encephalopathy 30.6 SCN1A POLG PCDH19
4 seizure disorder 30.3 SCN1A POLG PCDH19
5 focal epilepsy 29.9 SCN1A IL1RN
6 dravet syndrome 29.8 SCN1A PCDH19
7 west syndrome 29.4 SCN1A PCDH19 IL1RN
8 new-onset refractory status epilepticus 11.3
9 ocular motor apraxia 10.6
10 encephalitis 10.6
11 subacute delirium 10.4
12 autoimmune disease 10.3
13 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.3
14 cyanosis, transient neonatal 10.3
15 limbic encephalitis 10.3
16 dysgraphia 10.3
17 non-herpetic acute limbic encephalitis 10.3
18 pharyngitis 10.2
19 learning disability 10.2
20 autoimmune encephalitis 10.2
21 cerebral atrophy 10.2
22 febrile seizures 10.2
23 infectious encephalitis 10.2
24 non-alcoholic fatty liver disease 10.1
25 alacrima, achalasia, and mental retardation syndrome 10.1
26 agenesis of corpus callosum, cardiac, ocular, and genital syndrome 10.1
27 hemophagocytic lymphohistiocytosis 10.1
28 exanthem 10.1
29 middle east respiratory syndrome 10.1
30 hemiplegia 10.1
31 brain edema 10.1
32 viral encephalitis 10.1
33 herpes simplex 10.1
34 herpes simplex encephalitis 10.1
35 secondary hemophagocytic lymphohistiocytosis 10.1
36 rare epilepsy 10.1
37 plagiocephaly 10.0 SCN1A POLG
38 partial motor epilepsy 9.9 SCN1A POLG
39 landau-kleffner syndrome 9.9 SCN1A PCDH19
40 encephalopathy due to defective mitochondrial and peroxisomal fission 1 9.9 SCN1A POLG
41 developmental and epileptic encephalopathy 9 9.9 SCN1A PCDH19
42 infancy electroclinical syndrome 9.9 SCN1A PCDH19
43 adolescence-adult electroclinical syndrome 9.9 SCN1A PCDH19
44 photosensitive epilepsy 9.9 SCN1A PCDH19
45 benign neonatal seizures 9.9 SCN1A PCDH19
46 childhood electroclinical syndrome 9.9 SCN1A PCDH19
47 benign familial neonatal epilepsy 9.9 SCN1A PCDH19
48 unverricht-lundborg syndrome 9.9 SCN1A POLG
49 benign familial infantile epilepsy 9.9 SCN1A PCDH19
50 cytokine deficiency 9.9

Graphical network of the top 20 diseases related to Febrile Infection-Related Epilepsy Syndrome:



Diseases related to Febrile Infection-Related Epilepsy Syndrome
Sources

Symptoms & Phenotypes for Febrile Infection-Related Epilepsy Syndrome

About this section

Human phenotypes related to Febrile Infection-Related Epilepsy Syndrome:

58 31 (show all 12)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 eeg abnormality 58 31 hallmark (90%) Very frequent (99-80%) HP:0002353
2 developmental regression 58 31 hallmark (90%) Very frequent (99-80%) HP:0002376
3 lethargy 58 31 hallmark (90%) Very frequent (99-80%) HP:0001254
4 focal-onset seizure 58 31 hallmark (90%) Very frequent (99-80%) HP:0007359
5 behavioral abnormality 58 31 frequent (33%) Frequent (79-30%) HP:0000708
6 fever 58 31 frequent (33%) Frequent (79-30%) HP:0001945
7 sinusitis 58 31 frequent (33%) Frequent (79-30%) HP:0000246
8 myalgia 58 31 frequent (33%) Frequent (79-30%) HP:0003326
9 cough 58 31 frequent (33%) Frequent (79-30%) HP:0012735
10 headache 58 31 frequent (33%) Frequent (79-30%) HP:0002315
11 autoimmunity 58 31 occasional (7.5%) Occasional (29-5%) HP:0002960
12 sudden death 58 31 occasional (7.5%) Occasional (29-5%) HP:0001699
Sources

Drugs & Therapeutics for Febrile Infection-Related Epilepsy Syndrome

About this section

Drugs for Febrile Infection-Related Epilepsy Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 103)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Glycerol Approved, Investigational Phase 4 56-81-5 753
2
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
3
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
4
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
5 Insulin, Globin Zinc Phase 4
6 Soy Bean Phase 4
7 insulin Phase 4
8 Anti-Inflammatory Agents Phase 4
9 Analgesics, Non-Narcotic Phase 4
10 Fibrinolytic Agents Phase 4
11 Anti-Inflammatory Agents, Non-Steroidal Phase 4
12 Antirheumatic Agents Phase 4
13 Cyclooxygenase Inhibitors Phase 4
14 Platelet Aggregation Inhibitors Phase 4
15 Antipyretics Phase 4
16 Narcotics Phase 4
17 Analgesics, Opioid Phase 4
18 Narcotic Antagonists Phase 4
19 Buprenorphine, Naloxone Drug Combination Phase 4
20 Proton Pump Inhibitors Phase 2, Phase 3
21 Tissue Plasminogen Activator Phase 2, Phase 3
22
Levoleucovorin Approved, Investigational Phase 2 68538-85-2 149436
23
leucovorin Approved Phase 2 58-05-9 6006
24
Panitumumab Approved, Investigational Phase 2 339177-26-3 50070211
25
Fluorouracil Approved Phase 2 51-21-8 3385
26
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
27
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
28 Skullcap Phase 1, Phase 2
29 Protective Agents Phase 2
30 Nutrients Phase 2
31 Vitamin B Complex Phase 2
32 Micronutrients Phase 2
33 Hematinics Phase 2
34 Trace Elements Phase 2
35 Antineoplastic Agents, Immunological Phase 2
36 Vitamin B9 Phase 2
37 Vitamins Phase 2
38 Folate Phase 2
39 topoisomerase I inhibitors Phase 2
40 Antidotes Phase 2
41
Alprostadil Approved, Investigational 745-65-3 149351 5280723
42
Verapamil Approved 52-53-9 2520
43
Acetylcholine Approved, Investigational 51-84-3 187
44
Nitroprusside Approved, Investigational 15078-28-1 11963622
45
Memantine Approved, Investigational 19982-08-2 4054
46
Riluzole Approved, Investigational 1744-22-5 5070
47
Dopamine Approved 51-61-6, 62-31-7 681
48
Isradipine Approved, Investigational 75695-93-1 3784
49
Lidocaine Approved, Vet_approved 137-58-6 3676
50
Caffeine Approved 58-08-2 2519

Interventional clinical trials:

(show top 50) (show all 132)
# Name Status NCT ID Phase Drugs
1 The Adjuvant Magnesium Trial (AdMag): Assessment if the Impact of Oral Magnesium on ICD Firing and Quality of Life Unknown status NCT00282620 Phase 4 Magnesium L-lactate
2 Assessment of the Implementation of the ResQGARD® Impedance Threshold Device by the San Antonio Fire Department Completed NCT01780350 Phase 4
3 Fat, Inflammation and Insulin Resistance (FIRE-Study) Completed NCT01054989 Phase 4
4 Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting Completed NCT01276691 Phase 4 81 mg enteric coated aspirin
5 A Randomized Prospective Study of Endoscopy Bipolar Eletrocoagulation and Argon Plasma Coagulation of Chronic Rectal Bleeding From Radiation Telangiectasias Completed NCT00725244 Phase 4
6 Houston Emergency Opioid Engagement System (HEROES) Recruiting NCT03396276 Phase 4 Suboxone
7 The BIOPRES Trial; Transrectal BIOpsies of the PRostate: End Versus Side-firing Unknown status NCT00851292 Phase 3
8 Prospective Randomized Study of Cryotherapy Versus Argon Plasma Coagulation Therapy for Treatment Of Watermelon Stomach Completed NCT00587405 Phase 2, Phase 3
9 The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder Completed NCT03477799 Phase 3
10 BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Compared to Standard Management by Emergency Medical Services:The BEST-MSU Study Recruiting NCT02190500 Phase 2, Phase 3
11 Multicenter Study of Non-invasive Repetitive Paraorbital Alternating Current Stimulation of the Brain: Therapy for Aphasy Terminated NCT01277575 Phase 3
12 Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome (Acute Pericoronitis, Minor Recurrent Aphthous Stomatitis and Recurrent Herpes Simplex Labialis) Unknown status NCT03469232 Phase 1, Phase 2 Huanglian-Jiedu Decoction
13 Transcranial Direct Current Stimulation in Rehabilitation of Chronic Stroke Patients: Multicenter Clinical Trial Unknown status NCT02166619 Phase 2
14 Parent Training in Child Safety Practices Completed NCT02934633 Phase 2
15 Vibration Therapy Effects on Muscle Firing Patterns Completed NCT00510328 Phase 1, Phase 2
16 Application of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants and Assessment of Its Benefits Compared to Synchronized Intermittent Mandatory Ventilation (SIMV) With Pressure Support (PS) Completed NCT01389882 Phase 2
17 Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions Completed NCT01418820 Phase 2
18 Treating Primary Progressive Aphasia (PPA) and Elucidating Neurodegeneration in the Language Network Using Transcranial Direct Current Stimulation (tDCS) Recruiting NCT04046991 Phase 2
19 FIRE-5 -Study: Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation Not yet recruiting NCT04034173 Phase 2 Panitumumab;Irinotecan;Folinic acid;5-FU
20 A Multicenter, Phase II, Open Label Trial to Determine Optimal Imaging Parameters and Assess the Safety of LMI 1195 in Low Risk Patients and Heart Failure Patients With a History of Firing of an Implantable Cardioverter-Defibrillator Withdrawn NCT01085175 Phase 2 LMI 1195
21 Ease-it Spray for the Treatment of Fire Ant Stings Completed NCT00435552 Phase 1
22 Developing, Implementing and Evaluating Intervention Module on Preventing Fire, Burns and Scalds Injury Among Children Ages 7 to 11 Years In Sentul, Kuala Lumpur Unknown status NCT03618940
23 A Worldwide Post-Market Surveillance Registry to Assess the Medigus Ultrasonic Surgical Endostapler (MUSEâ„¢) System for the Treatment of GERD Unknown status NCT02366169
24 Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH Unknown status NCT02683980
25 Effect of Fire Suppression and Emergency Duties on Vascular Function in Firefighters Unknown status NCT01805063
26 Impact of Persistent Conductances on Motor Unit Firing in SCI Unknown status NCT02136823 sugar pill;Riluzole;Isradipine;Memantine
27 Keller Fire Rescue Study of Prehospital Ultrasound Use Unknown status NCT01074112
28 Effect of Real-fire Training on Vascular Function Unknown status NCT01812317
29 Dual Dispatch of EMS, Fire Fighters and/or Police in Out-of-hospital Cardiac Arrest Implemented in Nine Counties in Sweden - Can More Lives be Saved by Using This Method? Unknown status NCT02184468
30 Assessing the Impact of the Resilient Minds Program in Fire Departments Unknown status NCT03401684
31 Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial Unknown status NCT02964533
32 Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study Unknown status NCT02353533
33 Endobronchial Ultrasonography With a Guide Sheath Versus Computed Tomography-guided Transthoracic Needle Biopsy in the Diagnosis of Peripheral Pulmonary Lesions Unknown status NCT02740400
34 Improving Nutrition and Health Outcomes in Intibuca, Honduras Unknown status NCT01303016
35 A Randomised Control Trial to Compare the Pneupac VR1 Portable Ventilator and Manual Ven-tilation Via a Mapleson C- Circuit During the Intra-hospital Transfers of Intubated Patients Unknown status NCT02782871
36 Using mHealth Tools to Deliver Integrated Community Case Management (ICCM) to Village Health Team (VHT) Volunteers in Uganda. Unknown status NCT02971449
37 tDCS Guided by Interhemispheric Assimetry Level on Upper Limb Rehabilitation of Post Stroke Patients Completed NCT03446378
38 Worksite Exercise Interventions for Low Back Injury Prevention in Firefighters Completed NCT02362243
39 Effect of Omentectomy on Metabolic Syndrome, Acute Phase Reactants & Inflammatory Mediators in Patients Undergoing LRYGBP: A Randomized Trial Completed NCT00923260
40 Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique, in Investigating a Raised Prostatic Specific Antigen (PSA)? Completed NCT02761135
41 FIRE AND ICE Re-Ablations: Retrospective Data Collection on Re-ablations Performed Within the FIRE AND ICE Trial Completed NCT03314753
42 Therapeutic Effects of Acupuncture Plus Fire Needle Versus Acupuncture on Lateral Epicondylitis: A Randomized Case-control Pilot Study Completed NCT03820856
43 Group-based Intervention for Alcohol, Drugs and Aggression Among Club Patrons Completed NCT03652688
44 Is it Possible to Treat Cyanide Poisoning With HBO? Completed NCT00399100
45 Evaluation of Post-Exposure Sauna Treatment of Firefighters - A Pilot Study, Institutional Review Board# 1801201082 Completed NCT03429348
46 The Effectiveness of an On-line Training Program on Hospital Medical Staff to Improve Fire Knowledge Completed NCT02438150
47 Early Auditory Referral in Primary Care (EAR-PC) Completed NCT03004937
48 An EPIC Based BPA to Enhance Quit Line Referral and Use Completed NCT03229356
49 Smoking in the Paris Fire Brigade and Comparison According to the Type of Service (Permanent or On-call) Completed NCT04566198
50 Evaluation of Cardiac Arrest Recognition by Non-physicians Dispatchers in the Paris Fire Brigade Emergency Call Dispatch Center Completed NCT01992419

Search NIH Clinical Center for Febrile Infection-Related Epilepsy Syndrome

Sources

Genetic Tests for Febrile Infection-Related Epilepsy Syndrome

About this section
Sources

Anatomical Context for Febrile Infection-Related Epilepsy Syndrome

About this section

MalaCards organs/tissues related to Febrile Infection-Related Epilepsy Syndrome:

40
Prostate, Eye, Spinal Cord, Liver, Thalamus
Sources

Publications for Febrile Infection-Related Epilepsy Syndrome

About this section

Articles related to Febrile Infection-Related Epilepsy Syndrome:

(show top 50) (show all 108)
# Title Authors PMID Year
1
Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. 61 20
29399791 2018
2
New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. 20 61
29476535 2018
3
Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease. 61
33316111 2021
4
Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome. 61
33547757 2021
5
Claustrum hyperintensity: a rare radiological correlate in Niemann-Pick disease. 61
33495167 2021
6
Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. 61
33506622 2020
7
Improved seizure burden and cognitive performance in a child treated with responsive neurostimulation (RNS) following febrile infection related epilepsy syndrome (FIRES). 61
33331273 2020
8
Ketogenic diet and Neuroinflammation. 61
32987244 2020
9
Possible Role of High-Dose Barbiturates and Early Administration of Parenteral Ketogenic Diet for Reducing Development of Chronic Epilepsy in Febrile Infection-Related Epilepsy Syndrome: A Case Report. 61
33231274 2020
10
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. 61
32372459 2020
11
Whole-exome and HLA sequencing in Febrile infection-related epilepsy syndrome. 61
32666661 2020
12
Efficacy of different treatment modalities for acute and chronic phases of the febrile infection-related epilepsy syndrome: A systematic review. 61
32417686 2020
13
Diminished toll-like receptor response in febrile infection-related epilepsy syndrome (FIRES). 61
32651134 2020
14
Neurocritical care and target immunotherapy for febrile infection-related epilepsy syndrome. 61
32330681 2020
15
Application of ketogenic diets for pediatric neurocritical care. 61
32641260 2020
16
Therapeutic hypothermia for pediatric refractory status epilepticus May Ameliorate post-status epilepticus epilepsy. 61
32330677 2020
17
Extinguishing Febrile Infection-Related Epilepsy Syndrome: Pipe Dream or Reality? 61
32185792 2020
18
Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. 61
31957018 2020
19
An atypical case of febrile infection-related epilepsy syndrome following acute encephalitis: impact of physiotherapy in regaining locomotor abilities in a patient with neuroregression. 61
32774660 2020
20
Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES). 61
33403221 2020
21
Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy. 61
31171434 2019
22
Febrile infection-related epilepsy syndrome (FIRES) in an adult patient: an early neuroradiological finding. 61
31093785 2019
23
Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman. 61
31682750 2019
24
Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - Two different outcomes. 61
31446001 2019
25
Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus. 61
31283843 2019
26
Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome. 61
31168503 2019
27
The short-term and long-term outcome of febrile infection-related epilepsy syndrome in children. 61
31035103 2019
28
New onset refractory status epilepticus (NORSE). 61
30482654 2019
29
New onset refractory status epilepticus research: What is on the horizon? 61
30894443 2019
30
Treatment options in pediatric super-refractory status epilepticus. 61
30528076 2019
31
The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): A literature review. 61
30854647 2019
32
Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome. 61
30779222 2019
33
Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies. 61
31371963 2019
34
Ketogenic Diet as a Treatment for Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome. 61
31105638 2019
35
Febrile Infection-Related Epilepsy Syndrome (FIRES) with Multifocal Subcortical Infarcts, A New Imaging Phenotype. 61
29980149 2018
36
Fueling the FIRES: Hemophagocytic lymphohistiocytosis in febrile infection-related epilepsy syndrome. 61
30132834 2018
37
Febrile infection-related epilepsy syndrome (FIRES): therapeutic complications, long-term neurological and neuroimaging follow-up. 61
29453111 2018
38
Use of high b value diffusion-weighted magnetic resonance imaging in acute encephalopathy/encephalitis during childhood. 61
28838686 2018
39
Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents. 61
29745347 2018
40
Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies. 61
29203057 2018
41
Early ictal and interictal patterns in FIRES: The sparks before the blaze. 61
28555777 2017
42
Autoimmune Epilepsies. 61
29103423 2017
43
DNM1 encephalopathy: A new disease of vesicle fission. 61
28667181 2017
44
"Symptomatic" infection-associated acute encephalopathy in children with underlying neurological disorders. 61
27780632 2017
45
Effectiveness of Electroconvulsive Therapy for Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome. 61
27434885 2017
46
Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. 61
27919115 2017
47
Febrile infection-related epilepsy syndrome (FIRES) treated with immunomodulation in an 8-year-old boy and review of the literature. 61
29624228 2017
48
Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study. 61
28898171 2017
49
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases. 61
27655472 2017
50
Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy. 61
28078312 2017
Sources

Variations for Febrile Infection-Related Epilepsy Syndrome

About this section
Sources

Expression for Febrile Infection-Related Epilepsy Syndrome

About this section
Search GEO for disease gene expression data for Febrile Infection-Related Epilepsy Syndrome.
Sources

Pathways for Febrile Infection-Related Epilepsy Syndrome

About this section
Sources

GO Terms for Febrile Infection-Related Epilepsy Syndrome

About this section
Sources

Sources for Febrile Infection-Related Epilepsy Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....